Literature DB >> 16150646

Fcgamma-receptor IIA genotype and invasive pneumococcal infection.

Leen Moens1, Erna Van Hoeyveld, Jan Verhaegen, Kris De Boeck, Willy E Peetermans, Xavier Bossuyt.   

Abstract

Streptococcus pneumoniae is a major cause of pneumonia, bacteraemia, meningitis, and acute otitis media, especially in young children, immunocompromised patients, and elderly. Fcgamma-IIA receptor plays a crucial role in the phagocytosis of IgG2-opsonized bacteria since it is the sole receptor able to interact with IgG2 antibodies. Fcgamma-RIIA exhibits allelic polymorphisms with different capacities for binding IgG2 and phagocytosis. In a prospective study, we genotyped Fcgamma-RIIA in 55 Caucasian patients suffering from invasive pneumococcal disease and in 100 Caucasian controls. In contrast to previous reports, we found no association between Fcgamma-RIIA genotype and invasive pneumococcal disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16150646     DOI: 10.1016/j.clim.2005.08.002

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  8 in total

1.  Dynamics of the interaction of human IgG subtype immune complexes with cells expressing R and H allelic forms of a low-affinity Fc gamma receptor CD32A.

Authors:  Rangaiah Shashidharamurthy; Fang Zhang; Aaron Amano; Aparna Kamat; Ravichandran Panchanathan; Daniel Ezekwudo; Cheng Zhu; Periasamy Selvaraj
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

2.  The Fcgamma receptor IIA-R/R131 genotype is associated with severe sepsis in community-acquired pneumonia.

Authors:  Henrik Endeman; Marie Claire A Cornips; Jan C Grutters; Jules M van den Bosch; Hendrik J T Ruven; Heleen van Velzen-Blad; Ger T Rijkers; Douwe H Biesma
Journal:  Clin Vaccine Immunol       Date:  2009-06-03

3.  Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus.

Authors:  Brent W Kinder; Michelle M Freemer; Talmadge E King; Raymond F Lum; Joanne Nititham; Kim Taylor; Jeffrey C Edberg; S Louis Bridges; Lindsey A Criswell
Journal:  Arthritis Rheum       Date:  2007-08

4.  Rare variants in MYD88, IRAK4 and IKBKG and susceptibility to invasive pneumococcal disease: a population-based case-control study.

Authors:  Magda K Ellis; Katherine S Elliott; Anna Rautanen; Derrick W Crook; Adrian V S Hill; Stephen J Chapman
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

Review 5.  Protection Against Invasive Infections in Children Caused by Encapsulated Bacteria.

Authors:  Manish Sadarangani
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

6.  Host genetic variability and pneumococcal disease: a systematic review and meta-analysis.

Authors:  Anne T Kloek; Matthijs C Brouwer; Diederik van de Beek
Journal:  BMC Med Genomics       Date:  2019-09-13       Impact factor: 3.063

7.  Fcγ Receptor IIa (FCGR2A) Polymorphism Is Associated With Severe Respiratory Syncytial Virus Disease in Argentinian Infants.

Authors:  María Pía Holgado; Silvina Raiden; Inés Sananez; Vanesa Seery; Leonardo De Lillo; Lucas L Maldonado; Laura Kamenetzky; Jorge Geffner; Lourdes Arruvito
Journal:  Front Cell Infect Microbiol       Date:  2020-12-18       Impact factor: 5.293

8.  Nitric oxide synthase 2A (NOS2A) polymorphisms are not associated with invasive pneumococcal disease.

Authors:  Antony Payton; Debbie Payne; Limangeni A Mankhambo; Daniel L Banda; C Anthony Hart; William Er Ollier; Enitan D Carrol
Journal:  BMC Med Genet       Date:  2009-03-23       Impact factor: 2.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.